Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study

The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany

“…Comorbidity and older age are important risk factors for deviation from guideline-based treatment decision [ 20 ]. Older patients are generally treated less aggressively, for instance, with aggressive radiochemotherapy [ 18 , 21 , 22 , 23 , 24 , 25 ], and older patients and their families are more likely to refuse invasive treatment [ 26 , 27 ]. The DRG dataset used did not allow an analysis of the comorbidity of the patients.…”

Factors Affecting the Compliance of Curative Intent Treatment in Patients with Head and Neck Cancer

“…The authors found that patients with advanced cancer stages, advanced age, and treatment plans of best supportive care (BSC) or surgery combined with radiation (RT), chemotherapy (CT), or chemoradiation (CCRT) were more likely to have discordance with their treatment plan. [13] In 2006, under the United Kingdom NHS system, Duvvi et al proposed a two-week rule for suspected head and neck cancer and reported that compliance with the two-week referral guidelines was associated with a higher cancer detection rate and hopefully demonstrated an improvement in outcome. [14] In India, it has been demonstrated that early treatment decisions and referral could significantly improve patient dropout rates and possibly compliance with treatment.…”

Association between multidisciplinary team care and the completion of treatment for oral squamous cell carcinoma: A cohort population‐based study

“…The checklist used to gather patient information regarding reasons for failure to complete was based on interviews with patients who had terminated treatment before completion, previous studies (Chang et al, 2020; Chiang et al, 2018), patient medical records and expert opinions. The checklist contained 7 items: (1) Poor physical condition (chronic disease or uncontrolled systemic disease), difficulty enduring physical discomfort caused by treatment; (2) Patient, family or friends experienced negative treatment effects and worried about treatment side effects; (3) Transportation inconvenient; (4) Death; (5) Primary physician determined that the patient's physical condition precluded active treatment; (6) Poor familial support; and (7) Suicidal intentions.…”

“…The MDTC approach is proven effective for managing treatment for a variety of cancers. Studies show that MDTC can optimise a complex care plan (Badran et al, 2018), promote treatment compliance (Chang et al, 2020; Kelly et al, 2013; Liao et al, 2016; Rosell et al, 2018), enhance the quality of life post‐treatment (Stephens et al, 2006) and prolong survival (Forrest et al, 2005; Liao et al, 2016). In European countries, the MDTC approach is standard for cancer care and required for cancer centre accreditation by the Organization of European Cancer Institutes (European Partnership Action Against Cancer Consensus Group et al, 2014).…”

“…Although previous cancer‐related studies have explored this issue, most research has focused on HNC (Badran et al, 2018; Chang et al, 2020; Kelly et al, 2013), oesophageal cancer (Stephens et al, 2006), lung cancer (Forrest et al, 2005), health professionals (Rosell et al, 2018), quality of life (Stephens et al, 2006) and survival (Forrest et al, 2005; Liao et al, 2016). OSCC patients face much suffering, including psychological effects and disease burden, which may affect treatment decisions.…”